Axa’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-194,200
Closed -$9.45M 1254
2022
Q1
$9.45M Sell
194,200
-1,800
-0.9% -$80.5K 0.03% 487
2021
Q4
$8.18M Buy
+196,000
New +$8.23M 0.02% 545
2021
Q1
Sell
-9,700
Closed -$502K 1373
2020
Q4
$502K Sell
9,700
-39,400
-80% -$1.87M ﹤0.01% 1066
2020
Q3
$2.14M Sell
49,100
-180,400
-79% -$8.02M 0.01% 801
2020
Q2
$9.51M Hold
229,500
0.04% 450
2020
Q1
$7.54M Buy
229,500
+107,400
+88% +$5.13M 0.04% 426
2019
Q4
$6.68M Sell
122,100
-12,900
-10% -$663K 0.03% 544
2019
Q3
$6.49M Sell
135,000
-1,800
-1% -$86.2K 0.03% 570
2019
Q2
$6.76M Buy
136,800
+52,043
+61% +$2.79M 0.03% 567
2019
Q1
$4.99M Buy
+84,757
New +$4.62M 0.02% 648
2018
Q3
Sell
-11,386
Closed -$741K 1410
2018
Q2
$741K Sell
11,386
-3,592
-24% -$232K ﹤0.01% 1070
2018
Q1
$949K Buy
14,978
+10,100
+207% +$707K ﹤0.01% 1014
2017
Q4
$347K Buy
+4,878
New +$328K ﹤0.01% 1210
2015
Q1
Sell
-8,846
Closed -$361K 1504
2014
Q4
$361K Buy
+8,846
New +$313K ﹤0.01% 1165

Other funds holding CDK

Axa's CDK Position: Q2 2022 in Review

Axa sold out of CDK Global, Inc. (CDK) in Q2 2022, closing a stake of 194,200 shares — an estimated $9.45M sold.

Axa first reported a position in CDK in Q4 2014 and held it in 14 quarters. The position peaked at $9.51M in Q2 2020. 456 funds tracked by Wall St. Rank hold CDK as of Q2 2022.

  • Axa reported no remaining CDK Global, Inc. position as of Q2 2022 after selling out during the quarter.
  • Axa sold 194,200 CDK Global, Inc. shares in Q2 2022, an estimated $9.45M.
  • Axa first reported a position in CDK Global, Inc. in Q4 2014 and held it in 14 quarters.
  • Axa's CDK Global, Inc. position peaked at $9.51M in Q2 2020.
  • 456 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.